Type I Collagen C-telopeptide
Low bone turnover in premenopausal women with type 2 diabetes mellitus as an early process of diabetes-associated bone alterations: a cross-sectional study
8
Safety, tolerability and efficacy of intra articular Progenza in knee osteoarthritis: a randomized double blind placebo controlled single ascending dose study
13
Effect of Phase I Therapy on Salivary Carboxyterminal Telopetide of Type I Collagen in Chronic Periodontitis Patients
102
The role of enteric hormone GLP-2 in the response of bone markers to a mixed meal in postmenopausal women with type 2 diabetes mellitus
6
The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance
13
Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD
6
Serum concentrations of carboxyl terminal propeptide of type I procollagen, amino terminal propeptide of type III procollagen, cross linked carboxl terminal telopeptide of type I collagen, and their interrelationships in schoolchildren
5
POSTPRANDIAL RESPONSES OF SERUM CALCIUM, PARATHYROID HORMONE AND C TELOPEPTIDE OF TYPE I COLLAGEN TO THREE DOSES OF CALCIUM DELIVERED IN MILK
11
Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]
12
Impact of low dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two year randomized study
12
Biochemical markers of ongoing joint damage in rheumatoid arthritis current and future applications, limitations and opportunities
20
THE THERAPEUTIC POTENTIAL OF FRESH GOAT’s MILK AGAINST PREMATURE OSTEOPOROSIS BY INHIBITING OF BIOMARKERS OF BONE RESORPTION IN UNTRAINED HEALTHY WOMEN
5
Mauntel_unc_0153D_16326.pdf
174
Hormone Therapy Reduces Bone Resorption but not Bone Formation in Postmenopausal Athletes
7
Antiresorptive effect of a cathepsin K inhibitor ONO 5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis
9
Review Article Serum cross-linked N-telopeptide of type I collagen as a biomarker of bone metastases for patients with lung cancer: a meta-analysis
6
Tissue turnover of collagen type I, III and elastin is elevated in the PCLS model of IPF and can be restored back to vehicle levels using a phosphodiesterase inhibitor
10
Urinary Excretion of Cross-Linked N-Telopeptides of Type 1 Collagen to Assess Bone Resorption in Infants From Birth to 1 Year of Age
7
Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men
7
New diagnostic modalities and emerging treatments for neonatal bone disease
20